Trial Profile
Efficacy of Secretin Assisted Dynamic MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis(AIP)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Secretin (Primary)
- Indications Pancreatitis
- Focus Diagnostic use
- Acronyms S-MRCP
- 08 Jan 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 30 Jan 2018 Planned End Date changed from 1 Apr 2014 to 1 Dec 2018.
- 30 Jan 2018 Planned primary completion date changed from 1 Feb 2014 to 1 Dec 2018.